Fertility and sterility · 2011
Ovarian hyperstimulation syndrome in a patient treated with tamoxifen for breast cancer.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Baigent Amy, Lashen Hany
Аннотация
OBJECTIVE: To report the management of a rare case of ovarian hyperstimulation syndrome (OHSS) induced by tamoxifen therapy for breast cancer in a 50-year-old woman.
DESIGN: Case report.
SETTING: Gynecology outpatient department of a university hospital.
PATIENT(S): A 50-year-old premenopausal patient with a history of breast cancer was prescribed adjuvant treatment with tamoxifen.
INTERVENTION(S): Temporary discontinuation of tamoxifen therapy resolved symptoms, but resumption of tamoxifen caused a recurrence of symptoms. Surgical bilateral salpingo-oophrectomy was therefore performed.
MAIN OUTCOME MEASURE(S): Resolution of symptoms of OHSS.
RESULT(S): Bilateral salpingo-oophrectomy rendered the patient postmenopausal and enabled the commencement of the aromatase inhibitor anastrozole as an alternative adjuvant therapy for breast cancer.
CONCLUSION(S): Tamoxifen-induced OHSS is rare. Furthermore, OHSS is very rare in the older female. OHSS usually resolves with temporary discontinuation of tamoxifen, however, the recurrence of symptoms when resuming tamoxifen is better treated with bilateral salpingo-oophorectomy to enable adjuvant treatment with anastrazole.
DESIGN: Case report.
SETTING: Gynecology outpatient department of a university hospital.
PATIENT(S): A 50-year-old premenopausal patient with a history of breast cancer was prescribed adjuvant treatment with tamoxifen.
INTERVENTION(S): Temporary discontinuation of tamoxifen therapy resolved symptoms, but resumption of tamoxifen caused a recurrence of symptoms. Surgical bilateral salpingo-oophrectomy was therefore performed.
MAIN OUTCOME MEASURE(S): Resolution of symptoms of OHSS.
RESULT(S): Bilateral salpingo-oophrectomy rendered the patient postmenopausal and enabled the commencement of the aromatase inhibitor anastrozole as an alternative adjuvant therapy for breast cancer.
CONCLUSION(S): Tamoxifen-induced OHSS is rare. Furthermore, OHSS is very rare in the older female. OHSS usually resolves with temporary discontinuation of tamoxifen, however, the recurrence of symptoms when resuming tamoxifen is better treated with bilateral salpingo-oophorectomy to enable adjuvant treatment with anastrazole.